文献速递艾滋病与性传播感染病毒性肝炎

HIV感染者中非酒精性脂肪性肝病与2型糖尿病的16年自然病程:合并与不合并cART相关脂肪营养不良的比较

Natural Course of Nonalcoholic Fatty Liver Disease and Type 2 Diabetes in Patients With Human Immunodeficiency Virus With and Without Combination Antiretroviral Therapy-associated Lipodystrophy: A 16-Year Follow-up Study.
PubMed 文献 · Clin Infect Dis · 2020-01-01

本研究对41例HIV感染者(合并/不合并脂肪营养不良)及28名健康对照进行16年纵向随访,用质子磁共振波谱测肝脏脂肪含量,16年时用瞬时弹性成像和磁共振弹性成像评估肝纤维化。HIV感染者体脂增加更多、胰岛素抵抗加重,20%新发2型糖尿病而对照无新发;肝脏脂肪含量在各组保持稳定,进展为NAFLD罕见。

要点

  • HIV感染者16年随访中新发2型糖尿病达20%,而健康对照为0%。
  • 合并脂肪营养不良的HIV感染者基线肝脏脂肪含量显著高于不合并者。
  • 随访期间各组肝脏脂肪含量保持稳定,NAFLD进展罕见。

核心结论

  • 在16年随访中,HIV感染者NAFLD进展相较于2型糖尿病的发生较为罕见。

研究设计与样本

  • 纵向研究纳入41例HIV感染者(合并与不合并脂肪营养不良)和28名健康对照,基线及16年后测肝脏脂肪含量,16年时用瞬时弹性成像和磁共振弹性成像评估肝纤维化。

主要发现

  • 随访期间HIV感染者体脂增加8.6%±0.7%,高于对照的4.5%±0.6%(P < .001)。
  • HIV感染者胰岛素抵抗特征显著增加,而对照无显著增加。
  • 20%的HIV感染者新发2型糖尿病(P < .01 vs 基线0%),对照无新发。
  • 基线肝脏脂肪含量在合并脂肪营养不良的HIV感染者中为4.3(1.9-11.8),显著高于不合并者的1.0(0.5-1.5)(P < .001)。
  • 随访期间所有组肝脏脂肪含量保持稳定;磁共振弹性成像显示合并脂肪营养不良者中3例有进展期纤维化,不合并者无。

临床怎么用

  • 对HIV感染者长期随访应重视2型糖尿病的筛查与预防,而非仅关注NAFLD进展。
  • 合并脂肪营养不良的HIV感染者基线肝脏脂肪含量较高,需关注肝纤维化评估。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

BACKGROUND: Abnormal glucose metabolism and nonalcoholic fatty liver disease (NAFLD) are common in patients with human immunodeficiency virus (HIV+ patients), but longitudinal data are lacking. We determined the natural course of NAFLD (liver fat [LFAT]) and type 2 diabetes mellitus (T2DM) in HIV+ patients with and without lipodystrophy (LD+ and LD-, respectively) during a 16-year longitudinal study. METHODS: LFAT (by proton magnetic resonance spectroscopy) and clinical characteristics were measured in 41 HIV+ patients at baseline and after 16 years. Liver fibrosis was estimated by measuring liver stiffness using transient elastography (TE) and magnetic resonance elastography (MRE) at 16 years. We also longitudinally studied 28 healthy subjects. RESULTS: During follow-up, the HIV+ patients gained more body fat (8.6% ± 0.7%) than the control patients (4.5% ± 0.6%, P < .001). Features of insulin resistance increased significantly in the HIV+ patients but not the control patients. A significant proportion (20%, P < .01 vs 0% at baseline) of the HIV+ but none of the control patients developed T2DM. LFAT was significantly higher at baseline in the LD+ (4.3 [1.9-11.8]) than the LD- (1.0 [0.5-1.5]; P < .001) HIV+ patients. LFAT remained stable during follow-up in all groups. At follow-up, liver stiffness measured with TE was similar among all HIV, LD+, LD-, and control patients and between the LD+ and LD- patients measured with MRE. Advanced fibrosis by MRE was observed in 3 of LD+ and none of LD- patients. CONCLUSIONS: During 16 years of follow-up, progression of NAFLD is rare compared to development of T2DM in HIV+ patients.

来源:Clin Infect Dis,查看原文。版权归原作者所有。

引用

  1. Lallukka-Brück S, Isokuortti E, Luukkonen PK, et al. Natural Course of Nonalcoholic Fatty Liver Disease and Type 2 Diabetes in Patients With Human Immunodeficiency Virus With and Without Combination Antiretroviral Therapy-associated Lipodystrophy: A 16-Year Follow-up Study. Clin Infect Dis. 2020. PMID: 31131845. doi:10.1093/cid/ciz435

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。